Insider Transactions in Q4 2021 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2021
|
Jacqueline Wright Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,858
+50.0%
|
-
|
|
Dec 15
2021
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,621
-0.45%
|
$44,557
$17.0 P/Share
|
|
Dec 15
2021
|
Jeffrey Hessekiel EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
9,994
+1.67%
|
-
|
|
Dec 15
2021
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,131
-1.36%
|
$87,227
$17.0 P/Share
|
|
Dec 15
2021
|
Christopher J. Senner EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,491
+4.91%
|
-
|
|
Dec 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Open market or private sale
|
Direct |
47,500
-11.57%
|
$807,500
$17.44 P/Share
|
|
Dec 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,500
+10.37%
|
$285,000
$6.21 P/Share
|
|
Dec 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,646
-1.26%
|
$78,982
$17.0 P/Share
|
|
Dec 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
BUY
Grant, award, or other acquisition
|
Direct |
18,741
+4.85%
|
-
|
|
Dec 15
2021
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,556
-0.63%
|
$26,452
$17.0 P/Share
|
|
Dec 15
2021
|
Patrick J. Haley EVP, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
8,995
+3.52%
|
-
|
|
Dec 15
2021
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,236
-5.63%
|
$208,012
$17.0 P/Share
|
|
Dec 15
2021
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
46,478
+17.62%
|
-
|
|
Nov 29
2021
|
Michael Morrissey President and CEO |
BUY
Bona fide gift
|
Indirect |
196,524
+13.73%
|
-
|
|
Nov 29
2021
|
Michael Morrissey President and CEO |
SELL
Bona fide gift
|
Direct |
196,524
-53.51%
|
-
|
|
Nov 24
2021
|
Patrick J. Haley EVP, Commercial |
SELL
Open market or private sale
|
Direct |
17,236
-6.76%
|
$293,012
$17.25 P/Share
|
|
Nov 19
2021
|
Carl B Feldbaum Director |
SELL
Open market or private sale
|
Direct |
20,000
-70.12%
|
$340,000
$17.62 P/Share
|
|
Nov 19
2021
|
Carl B Feldbaum Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+41.22%
|
$60,000
$3.13 P/Share
|
|
Nov 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
62,163
-5.14%
|
$1,118,934
$18.1 P/Share
|
|
Nov 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Open market or private sale
|
Direct |
47,500
-10.35%
|
$855,000
$18.09 P/Share
|
|
Nov 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,500
+9.38%
|
$285,000
$6.21 P/Share
|
|
Nov 15
2021
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
193,780
-11.84%
|
$3,488,040
$18.1 P/Share
|
|
Nov 15
2021
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
54,611
-2.91%
|
$982,998
$18.1 P/Share
|
|
Nov 15
2021
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
57,713
-4.73%
|
$1,038,834
$18.1 P/Share
|
|
Nov 15
2021
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
49,490
-5.5%
|
$890,820
$18.1 P/Share
|
|
Nov 01
2021
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
5,117
-0.8%
|
$112,574
$22.03 P/Share
|
|
Oct 22
2021
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,747
-4.22%
|
$519,687
$21.33 P/Share
|
|
Oct 22
2021
|
Michael Morrissey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
94,002
+13.83%
|
-
|
|
Oct 15
2021
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
12,883
-1.98%
|
$283,426
$22.02 P/Share
|
|
Oct 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
SELL
Open market or private sale
|
Direct |
47,500
-10.35%
|
$997,500
$21.92 P/Share
|
|
Oct 15
2021
|
Peter Lamb EVP, Scientific Strategy & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,500
+9.38%
|
$285,000
$6.21 P/Share
|